StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2024, quý kết thúc ngày Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

AXIM Biotechnologies's enterprise value was $1.08M on Oct 19, 2026, against $3.13M a year earlier. Over the last 5 years it ranged from $739.92K to $59.87M, with a median of $3.45M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$1.08M-67.5%
2025Dec 31, 2025$3.33M+350.2%
2024Dec 31, 2024$739.92K-83.9%
2023Dec 29, 2023$4.58M+23.8%
2022Dec 30, 2022$3.70M-93.8%
2021Dec 31, 2021$59.87M+12.8%
2020Dec 31, 2020$53.05M+143.9%
2019Dec 31, 2019$21.75M-51.0%
2018Dec 31, 2018$44.39M-91.2%
2017Dec 29, 2017$501.64M+12.2%
2016Dec 30, 2016$447.12M+3700.0%
2015Dec 31, 2015$11.77M-96.4%
2014Dec 31, 2014$329.05M–

More AXIM Biotechnologies figures

See a number that looks wrong?